This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Catheter-Related Infections
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

Patients on long-term parenteral nutrition (PN) are at high risk for central line-associated bloodstream infections (CLABSI). This study evaluates the efficacy and safety of ethanol lock therapy for CLABSI prophylaxis in adult patients on PN.

Provided treatments

  • Other: Ethanol lock
  • Other: Heparin lock

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02890875. The sponsor of the trial is Stanford University and it is looking for 3 volunteers for the current phase.
Official trial title:
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections